Reaction
Sjs-Ten Overlap reporting signals
As of the last recalculation, Sjs-Ten Overlap appears in 640 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is LAMOTIRIGINE (PRR 38.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lamotirigine | 75 | 38.4 | 38.5 |
| Lamotrigine Extended-Release | 75 | 38.4 | 38.5 |
| Lamotrigine Chewable Dispersible | 75 | 38.4 | 38.5 |
| Piperacillin Sodium,Tazobactam Sodium | 29 | 37.2 | 37.2 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 10 | 29.9 | 29.9 |
| Piperacillin And Tazobactam | 11 | 28.4 | 28.5 |
| Cefepime | 12 | 27.7 | 27.7 |
| Cefepime Hydrochloride | 12 | 24.7 | 24.7 |
| Lamotrigine | 85 | 24.0 | 24.1 |
| Phenytoin | 14 | 22.3 | 22.3 |
| Nevirapine | 6 | 21.8 | 21.8 |
| Efavirenz | 7 | 20.6 | 20.6 |
| Tenofovir Disoproxil Fumarate Tablets | 5 | 19.0 | 19.0 |